London Calling 2025 - Speakers
Speakers
Check out the line up of speakers at London Calling 2025.
Oxford Nanopore Technologies
Stephen Meyn
- Job title
- Institution
- Center for Human Genomics and Precision Medicine, University of Wisconsin–Madison, USA
- Biography
Dr. Meyn directs the Center for Human Genomics and Precision Medicine at the University of Wisconsin. Trained in pediatrics and medical genetics, Dr. Meyn has held faculty positions at Yale and the University of Toronto, where he co-led the Hospital for Sick Children’s Genome Clinic Project, which pioneered the use of diagnostic and predictive genome sequencing in children. His current research focuses on applying novel technologies to discovering disease genes and determining the role of structural genomic variants in human disease.
- Recent publications
Costain, G. et al. Genome sequencing as a diagnostic test in children with unexplained medical complexity. JAMA Network Open 3(9):e2018109 (2020). DOI: 10.1001/jamanetworkopen.2020.18109
Villani, A. et al. The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. Nat. Cancer 4(2):203–221 (2023). DOI: https://doi.org/10.1038/s43018-022-00474-y
Deshwar, A.R. et al. Trio RNA sequencing in a cohort of medically complex children. Am. J. Hum. Genet. 110(5):895–900 (2023). DOI: 10.1016/j.ajhg.2023.03.006
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.
